Spots Global Cancer Trial Database for etanercept
Every month we try and update this database with for etanercept cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug. | NCT01295151 | Rheumatoid Arth... | Etanercept Abatacept Rituximab Adalimumab Certolizumab Pe... Infliximab Golimumab | 18 Years - | University of Leeds | |
Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet | NCT00585650 | Psoriasis | Etanercept Placebo injecti... | 18 Years - 70 Years | University of California, Irvine | |
Etanercept in Rheumatoid Arthritis and Vascular Inflammation | NCT02109289 | Rheumatoid Arth... Vascular Inflam... | etanercept | 18 Years - 80 Years | Innovaderm Research Inc. | |
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis | NCT02092467 | Arthritis, Rheu... | tofacitinib tofacitinib adalimumab etanercept | 50 Years - | Pfizer | |
Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid Tumors | NCT00201812 | Tumors | Etanercept Docetaxel Dexamethasone | 18 Years - | Ohio State University Comprehensive Cancer Center | |
Advanced Therapeutics in Rheumatoid Arthritis (RA) | NCT03976245 | Rheumatoid Arth... | Etanercept tofacitinib | 18 Years - | Lawson Health Research Institute | |
A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV Disease | NCT00205231 | HIV Infections | etanercept | 18 Years - | University of Wisconsin, Madison | |
Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma | NCT00201682 | Chronic Lymphoc... Small Lymphocyt... | Etanercept Rituximab | 18 Years - | Ohio State University Comprehensive Cancer Center | |
Study Evaluating Etanercept in Moderate to Severe Asthma | NCT00141791 | Asthma | Etanercept | 18 Years - 70 Years | Wyeth is now a wholly owned subsidiary of Pfizer | |
Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis | NCT00432406 | Psoriatic Arthr... | Infliximab Etanercept | 18 Years - 70 Years | Chinese University of Hong Kong | |
TNF and Glucocorticoid Antagonist for GWI Associated Multi-symptom Disease Homeostasis Reset | NCT04254627 | Gulf War Illnes... | Etanercept Mifepristone | 45 Years - 70 Years | Nova Southeastern University | |
Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants | NCT01009879 | Rheumatoid Arth... | Etanercept | 18 Years - | University of Pittsburgh | |
Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA) | NCT03780959 | Juvenile Rheuma... | Etanercept Placebo | 4 Years - 18 Years | Amgen | |
Etanercept for Wegener's Granulomatosis | NCT00005007 | Wegener's Granu... | Etanercept | 11 Years - | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | |
Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma | NCT00201838 | Pancreatic Neop... Adenocarcinoma | Gemcitabine Etanercept | 18 Years - | Ohio State University Comprehensive Cancer Center | |
Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury | NCT00031551 | Stomatitis | Etanercept Placebo | 16 Years - | National Institutes of Health Clinical Center (CC) | |
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis | NCT02092467 | Arthritis, Rheu... | tofacitinib tofacitinib adalimumab etanercept | 50 Years - | Pfizer | |
A Pilot Study of Etanercept in Dermatomyositis | NCT00112385 | Dermatomyositis | Etanercept Placebo | 18 Years - 65 Years | Brigham and Women's Hospital | |
Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA) | NCT03780959 | Juvenile Rheuma... | Etanercept Placebo | 4 Years - 18 Years | Amgen | |
Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World" | NCT02878161 | Rheumatoid Arth... | methotrexate(ne... infliximab etanercept adalimumab leflunomide (pe... NSAIDs (permitt... Glucocorticoids... | 18 Years - 75 Years | Central South University | |
Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer | NCT00046904 | Anorexia Cachexia Unspecified Adu... | etanercept | 18 Years - | Mayo Clinic | |
Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis | NCT00432406 | Psoriatic Arthr... | Infliximab Etanercept | 18 Years - 70 Years | Chinese University of Hong Kong | |
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis | NCT02092467 | Arthritis, Rheu... | tofacitinib tofacitinib adalimumab etanercept | 50 Years - | Pfizer | |
Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia | NCT00509600 | Leukemia | Etanercept | 6 Months - 18 Years | M.D. Anderson Cancer Center | |
Can We Miss Pigmented Lesions in Psoriasis Patients? | NCT01053819 | Psoriasis Melanoma Non-melanoma Sk... | etanercept | 19 Years - | University of Alabama at Birmingham | |
Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome | NCT00111956 | Metabolic Syndr... | Etanercept Placebo | 18 Years - 55 Years | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |
SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug. | NCT01295151 | Rheumatoid Arth... | Etanercept Abatacept Rituximab Adalimumab Certolizumab Pe... Infliximab Golimumab | 18 Years - | University of Leeds | |
TNF Alpha in Refractory Asthma | NCT00276029 | Asthma | Etanercept | 18 Years - 65 Years | University Hospitals, Leicester | |
Study Evaluating Etanercept in Moderate to Severe Asthma | NCT00141791 | Asthma | Etanercept | 18 Years - 70 Years | Wyeth is now a wholly owned subsidiary of Pfizer | |
Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA) | NCT03780959 | Juvenile Rheuma... | Etanercept Placebo | 4 Years - 18 Years | Amgen | |
TNF Alpha in Refractory Asthma | NCT00276029 | Asthma | Etanercept | 18 Years - 65 Years | University Hospitals, Leicester | |
Etanercept for the Treatment of Lupus Nephritis | NCT00447265 | Lupus Nephritis | Etanercept Lupus Treatment... Placebo | 18 Years - 75 Years | National Institute of Allergy and Infectious Diseases (NIAID) | |
Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma | NCT00201838 | Pancreatic Neop... Adenocarcinoma | Gemcitabine Etanercept | 18 Years - | Ohio State University Comprehensive Cancer Center | |
Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis | NCT01793519 | Rheumatoid Arth... | Etanercept Infliximab Adalimumab Placebo | 18 Years - | Georgetown University | |
Etanercept to Treat Wegener's Granulomatosis | NCT00001901 | Vasculitis Wegener's Granu... | Etanercept | - | National Institutes of Health Clinical Center (CC) | |
Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma | NCT00201838 | Pancreatic Neop... Adenocarcinoma | Gemcitabine Etanercept | 18 Years - | Ohio State University Comprehensive Cancer Center | |
Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation | NCT00029328 | Respiratory Dis... Bronchiolitis O... Pneumonia | etanercept | 12 Months - | FDA Office of Orphan Products Development | |
Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant | NCT00141726 | Lung Injury, Ac... Respiratory Dis... Bronchiolitis O... | Etanercept | 6 Years - | University of Michigan Rogel Cancer Center | |
Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer | NCT00046904 | Anorexia Cachexia Unspecified Adu... | etanercept | 18 Years - | Mayo Clinic | |
Biological Therapy in Treating Patients With Myelodysplastic Syndrome | NCT00005853 | Leukemia Myelodysplastic... | anti-thymocyte ... etanercept | - | Fred Hutchinson Cancer Center | |
Biological Therapy in Treating Patients With Myelodysplastic Syndrome | NCT00005853 | Leukemia Myelodysplastic... | anti-thymocyte ... etanercept | - | Fred Hutchinson Cancer Center | |
Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer | NCT00046904 | Anorexia Cachexia Unspecified Adu... | etanercept | 18 Years - | Mayo Clinic | |
Etanercept in Rheumatoid Arthritis and Vascular Inflammation | NCT02109289 | Rheumatoid Arth... Vascular Inflam... | etanercept | 18 Years - 80 Years | Innovaderm Research Inc. | |
Azacitidine and Etanercept in Treating Patients With Myelodysplastic Syndromes | NCT00118287 | de Novo Myelody... Previously Trea... Secondary Myelo... | azacitidine etanercept | 18 Years - | Fred Hutchinson Cancer Center | |
Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer | NCT00046904 | Anorexia Cachexia Unspecified Adu... | etanercept | 18 Years - | Mayo Clinic | |
Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet | NCT00585650 | Psoriasis | Etanercept Placebo injecti... | 18 Years - 70 Years | University of California, Irvine | |
Etanercept to Treat Wegener's Granulomatosis | NCT00001901 | Vasculitis Wegener's Granu... | Etanercept | - | National Institutes of Health Clinical Center (CC) |